Pricing Log in Create free account

Bone Biologics Corp. (BBLG) vs Atrinsic Inc. (PTIX)

Bone Biologics Corp. and Atrinsic Inc. are both Biotechnology companies. Atrinsic Inc. is the larger, with a market value of $1.3M against $1.1M — 1.2× the size. Bone Biologics Corp. has negative trailing earnings, so its P/E is not meaningful; Atrinsic Inc. trades at 0.3×. Across the 9 metrics below, Atrinsic Inc. leads on 5 and Bone Biologics Corp. on 4.

Valuation

Metric BBLG PTIX Biotechnology median
P/E n/m 0.34 8.50
P/S n/m n/m 9.71
P/B 0.18 0.79 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (342.50%) 297.33% (33.15%)
Free cash flow yield (365.78%) (158.74%) (25.50%)

Profitability

Metric BBLG PTIX Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (54.96%) (338.24%) (56.36%)
Return on assets (50.55%) 378.63% (48.04%)
Return on invested capital 0.00% (229.86%) 0.00%

Growth

Metric BBLG PTIX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 90.85% 188.24% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BBLG PTIX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.67 0.66 4.72
Net debt to EBITDA 1.65 0.52 0.96

Dividend

Metric BBLG PTIX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BBLG PTIX Biotechnology median
Market cap 1.07m 1.27m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack